Syngene International is a leading Contract Research Organization (CRO) based in India. Established in 1993, it is a subsidiary of Biocon Limited, a prominent biopharmaceutical company. Syngene International is headquartered in Bengaluru, Karnataka, India.

The company offers a wide range of products and services in the pharmaceutical and biotechnology sectors. Its main expertise lies in drug discovery and development, providing integrated services to global pharmaceutical, biotechnology, and agrochemical companies. Syngene's services include discovery biology, medicinal chemistry, process research and development, manufacturing, and clinical development.

Operating on a global scale, Syngene has several noteworthy subsidiaries and partnerships. The company has a strong collaboration with Bristol Myers Squibb (BMS), a global biopharmaceutical company, to accelerate the discovery and development of new therapeutics. Syngene also has joint ventures with Novartis and Baxter to develop formulations for the Indian market.

These partnerships allow them to enhance their research capabilities and expand their market reach. In terms of market position, Syngene International has established a strong presence both locally and internationally. It is one of the largest CROs in India and has a significant market share in the region.

The company has also made substantial progress in expanding its global footprint, catering to clients from North America, Europe, and Asia. Syngene International has achieved several notable milestones in its journey. In 2013, the company completed its initial public offering, which was oversubscribed multiple times.

This marked a significant event in its funding and growth. Syngene has also undertaken strategic acquisitions to strengthen its service offerings and expand its capabilities. As of the latest updates, Syngene International continues to grow and innovate in the biopharmaceutical industry.

The company has been actively involved in research and development, focusing on expanding its capabilities in the areas of drug discovery and manufacturing. Syngene's dedication to excellence and its strong market position make it a key player in the global bio-pharma space. In conclusion, Syngene International is a leading contract research organization headquartered in Bengaluru, India.

It offers a wide range of services in the biopharmaceutical sector and has a strong market presence both domestically and globally. With strategic partnerships and collaborations, Syngene continues to strengthen its research capabilities and expand its client base. The company's commitment to innovation and growth positions it as a key player in the industry